UNC lab partnership develops first COVID-19 treatment approved by FDA

Posted Nov 7, 2020
Remdesivir, a drug developed through a partnership between UNC’s Baric Lab and Gilead Sciences, was recently approved as a COVID-19 treatment. As of Oct. 22, remdesivir is the first and only FDA-approved COVID-19 treatment in the U.S. UNC faculty and students reflected on the significance of remdesivir’s approval and what this means for the University. (Daily Tar Heel)

Related: Campus Connections

Best moments from ESPN documentary "Boo-Yah: A Portrait of Stuart Scott"
In 1984, Stuart Scott began attending the University of North Carolina, where he studied journalism. He became a member of Alpha Phi Alpha Fraternity Inc.,...
Thu Dec 18, 2025

UNC grad documents post-Helene recovery
In addition to Carolina’s Spring Commencement, Max Feliu ’25 had another May date circled on his calendar. The filmmaker’s nine-minute documentary on life after Hurricane...
Thu Dec 18, 2025

UNC Athletics Celebrates The Season With Team IMPACT
Carolina Athletics welcomed members of Team IMPACT and their families for a fun-filled day of holiday activities with student-athletes from various programs on Saturday. The...
Tue Dec 16, 2025

There Will Never Be Another Stuart Scott
For an entire generation of American sports fans, Stuart Scott loomed as large as the superstar athletes he covered. After 22 years at ESPN—bringing a...
Sun Dec 14, 2025